Eterna Therapeutics Financial Overview
Eterna Therapeutics's market cap is currently $10.05M. The company's EPS TTM is $-6.207; its P/E ratio is -0.26; Eterna Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
